Metraipolis › archive › dc_eddc5c12c58d

Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations — Europe PMC PMID:42197401

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42197401
DOI
10.3390/microorganisms14051015
License (as archived)
solo-consultazione
Archived
2026-11-02T20:58:54.058Z
SHA-256 of the archived text
790ac533bfa28c0107e391e46f7b48e81878300f5c8e6cf5839bea21de88556b
Stable URL of this page
https://metraipolis.com/documento/dc_eddc5c12c58d

How to cite

Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations — Europe PMC PMID:42197401 — Europe PMC (en), https://europepmc.org/article/MED/42197401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eddc5c12c58d (Metraipolis archive dc_eddc5c12c58d, sha256 790ac533bfa28c0107e391e46f7b48e81878300f5c8e6cf5839bea21de88556b)
BibTeX
@misc{dceddc5c12c58d,
  title = {Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin: Mechanisms of Action, Drug Interactions, Adverse Effects and Use in Special Situations — Europe PMC PMID:42197401},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42197401},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eddc5c12c58d; sha256 790ac533bfa28c0107e391e46f7b48e81878300f5c8e6cf5839bea21de88556b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42197401. Agents can read the archived copy with the MCP tool read_document.